Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer

Clinical trial NCT01715142 · COMPLETED

Trial details

NCT number: NCT01715142
Sponsor: Jean-Luc Van Laethem
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Resectable Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma Metastatic

Start date: 2013-03-21
Primary completion: 2015-09-21
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.